pathway	pval	padj	log2err	ES	NES	size	leadingEdge
"Neutrophil degranulation"	0.0136791934889464	0.7988893728223	0.380730400722792	0.825563794609216	1.57544684655138	6	ELANE CNN2 AZU1 CFD ARHGAP45
"Innate Immune System"	0.0237794004990225	0.7988893728223	0.352487857583619	0.72045933422527	1.54275966641923	9	ELANE CNN2 AZU1 CFD ARHGAP45 GZMM
"Immune System"	0.0546875	0.7988893728223	0.241339976815091	0.651905112701826	1.4473110030375	11	ELANE CNN2 AZU1 CFD ARHGAP45 GZMM
"Activation of NMDA receptors and postsynaptic events"	0.0586643663368488	0.7988893728223	0.321775918075361	0.985507246376812	1.31155740810912	1	GRIN3B
"Assembly and cell surface presentation of NMDA receptors"	0.0586643663368488	0.7988893728223	0.321775918075361	0.985507246376812	1.31155740810912	1	GRIN3B
"Neurotransmitter receptors and postsynaptic signal transmission"	0.0586643663368488	0.7988893728223	0.321775918075361	0.985507246376812	1.31155740810912	1	GRIN3B
"Transmission across Chemical Synapses"	0.0586643663368488	0.7988893728223	0.321775918075361	0.985507246376812	1.31155740810912	1	GRIN3B
"Diseases of signal transduction by growth factor receptors and second messengers"	0.072	0.7988893728223	0.237793834423688	-0.90758765582804	-1.37646007936969	2	FGF22
"FGFR2 mutant receptor activation"	0.072	0.7988893728223	0.237793834423688	-0.90758765582804	-1.37646007936969	2	FGF22
"Signaling by FGFR in disease"	0.072	0.7988893728223	0.237793834423688	-0.90758765582804	-1.37646007936969	2	FGF22
"Signaling by FGFR2 in disease"	0.072	0.7988893728223	0.237793834423688	-0.90758765582804	-1.37646007936969	2	FGF22
"Degradation of the extracellular matrix"	0.0752475247524752	0.7988893728223	0.231126709673834	0.922870006955308	1.33557036514035	2	ELANE BSG
"Intracellular signaling by second messengers"	0.076	0.7988893728223	0.231126709673834	-0.900190929298216	-1.36524210089572	2	FGF22
"PIP3 activates AKT signaling"	0.076	0.7988893728223	0.231126709673834	-0.900190929298216	-1.36524210089572	2	FGF22
"MAPK family signaling cascades"	0.0932203389830508	0.7988893728223	0.213927855492356	-0.835820895522388	-1.41039785748916	3	FGF22 SHC2 ABHD17A
"MAPK1/MAPK3 signaling"	0.0932203389830508	0.7988893728223	0.213927855492356	-0.835820895522388	-1.41039785748916	3	FGF22 SHC2 ABHD17A
"RAF/MAP kinase cascade"	0.0932203389830508	0.7988893728223	0.213927855492356	-0.835820895522388	-1.41039785748916	3	FGF22 SHC2 ABHD17A
"Activation of Matrix Metalloproteinases"	0.103921568627451	0.7988893728223	0.193813302725311	0.956521739130435	1.27298219022356	1	ELANE
"Collagen degradation"	0.103921568627451	0.7988893728223	0.193813302725311	0.956521739130435	1.27298219022356	1	ELANE
"Programmed Cell Death"	0.103921568627451	0.7988893728223	0.193813302725311	0.956521739130435	1.27298219022356	1	ELANE
Pyroptosis	0.103921568627451	0.7988893728223	0.193813302725311	0.956521739130435	1.27298219022356	1	ELANE
"Regulated Necrosis"	0.103921568627451	0.7988893728223	0.193813302725311	0.956521739130435	1.27298219022356	1	ELANE
"Regulation of Complement cascade"	0.103921568627451	0.7988893728223	0.193813302725311	0.956521739130435	1.27298219022356	1	ELANE
"Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation"	0.137254901960784	0.7988893728223	0.166933848713193	0.942028985507246	1.25369458128078	1	CNN2
"Interleukin-12 family signaling"	0.137254901960784	0.7988893728223	0.166933848713193	0.942028985507246	1.25369458128078	1	CNN2
"Interleukin-12 signaling"	0.137254901960784	0.7988893728223	0.166933848713193	0.942028985507246	1.25369458128078	1	CNN2
"Activated point mutants of FGFR2"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"Constitutive Signaling by Aberrant PI3K in Cancer"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"Downstream signaling of activated FGFR1"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"Downstream signaling of activated FGFR2"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"FGFR1 ligand binding and activation"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"FGFR1b ligand binding and activation"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"FGFR2 ligand binding and activation"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"FGFR2b ligand binding and activation"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"FGFRL1 modulation of FGFR1 signaling"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"FRS-mediated FGFR1 signaling"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"FRS-mediated FGFR2 signaling"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"IGF1R signaling cascade"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"IRS-mediated signalling"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"IRS-related events triggered by IGF1R"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"Insulin receptor signalling cascade"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"Negative regulation of FGFR1 signaling"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"Negative regulation of FGFR2 signaling"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"Negative regulation of the PI3K/AKT network"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"PI-3K cascade:FGFR1"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"PI-3K cascade:FGFR2"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"PI3K Cascade"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"PI3K/AKT Signaling in Cancer"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"Phospholipase C-mediated cascade: FGFR1"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"Phospholipase C-mediated cascade; FGFR2"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"SHC-mediated cascade:FGFR1"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"SHC-mediated cascade:FGFR2"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"Signaling by FGFR1"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"Signaling by Insulin receptor"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"	0.140243902439024	0.7988893728223	0.16823816568964	-0.956521739130435	-1.23857208377923	1	FGF22
"Ion channel transport"	0.158823529411765	0.844411764705882	0.154190966581424	0.927536231884058	1.234406972338	1	ATP8B3
"Ion transport by P-type ATPases"	0.158823529411765	0.844411764705882	0.154190966581424	0.927536231884058	1.234406972338	1	ATP8B3
"TP53 Regulates Transcription of Cell Cycle Genes"	0.158823529411765	0.844411764705882	0.154190966581424	0.91304347826087	1.21511936339522	1	ARID3A
"TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"	0.158823529411765	0.844411764705882	0.154190966581424	0.91304347826087	1.21511936339522	1	ARID3A
Metabolism	0.176795580110497	0.903792840822544	0.175204047558551	-0.491135591724505	-1.26533753099244	11	NDUFS7 UQCR11 STK11 GAMT GPX4 ATP5F1D MED16
"FGFR2 alternative splicing"	0.184158415841584	0.903792840822544	0.142901149386948	0.845624882720429	1.22378181637165	2	PTBP1 POLR2E
"Processing of Capped Intron-Containing Pre-mRNA"	0.184158415841584	0.903792840822544	0.142901149386948	0.845624882720429	1.22378181637165	2	PTBP1 POLR2E
"mRNA Splicing"	0.184158415841584	0.903792840822544	0.142901149386948	0.845624882720429	1.22378181637165	2	PTBP1 POLR2E
"mRNA Splicing - Major Pathway"	0.184158415841584	0.903792840822544	0.142901149386948	0.845624882720429	1.22378181637165	2	PTBP1 POLR2E
"Signaling by NTRK1 (TRKA)"	0.207317073170732	0.931466849879766	0.135740943810425	-0.927536231884058	-1.20103959639198	1	SHC2
"Signaling by NTRKs"	0.207317073170732	0.931466849879766	0.135740943810425	-0.927536231884058	-1.20103959639198	1	SHC2
"Signaling by VEGF"	0.207317073170732	0.931466849879766	0.135740943810425	-0.927536231884058	-1.20103959639198	1	SHC2
"Signalling to ERKs"	0.207317073170732	0.931466849879766	0.135740943810425	-0.927536231884058	-1.20103959639198	1	SHC2
"Signalling to RAS"	0.207317073170732	0.931466849879766	0.135740943810425	-0.927536231884058	-1.20103959639198	1	SHC2
"VEGFA-VEGFR2 Pathway"	0.207317073170732	0.931466849879766	0.135740943810425	-0.927536231884058	-1.20103959639198	1	SHC2
"Complement cascade"	0.227443609022556	0.934170410783055	0.123257226381337	0.761194029850746	1.21856414445091	3	ELANE CFD GZMM
"HCN channels"	0.241869918699187	0.934170410783055	0.124434168630393	-0.91304347826087	-1.18227335269836	1	HCN2
"Potassium Channels"	0.241869918699187	0.934170410783055	0.124434168630393	-0.91304347826087	-1.18227335269836	1	HCN2
"Antimicrobial peptides"	0.285148514851485	0.934170410783055	0.11146266692298	0.803443253406334	1.16273688735603	2	ELANE PRTN3
"Lysosphingolipid and LPA receptors"	0.32520325203252	0.934170410783055	0.104732821580651	-0.869565217391304	-1.12597462161748	1	PLPPR3
"Platelet activation, signaling and aggregation"	0.325490196078431	0.934170410783055	0.102449405629826	0.855072463768116	1.13796892762409	1	CFD
"Platelet degranulation "	0.325490196078431	0.934170410783055	0.102449405629826	0.855072463768116	1.13796892762409	1	CFD
"Response to elevated platelet cytosolic Ca2+"	0.325490196078431	0.934170410783055	0.102449405629826	0.855072463768116	1.13796892762409	1	CFD
"Transcriptional Regulation by TP53"	0.333333333333333	0.934170410783055	0.0946646223153342	0.661573633134541	1.13987517245787	4	ARID3A POLR2E MBD3
"Respiratory electron transport"	0.334	0.934170410783055	0.102080107662747	-0.764705882352941	-1.15976359171354	2	NDUFS7 UQCR11
"Gene expression (Transcription)"	0.351219512195122	0.934170410783055	0.0870515867946735	0.531559140529253	1.09710469791438	8	ARID3A TCF3 POLRMT POLR2E MBD3 MED16 GAMT STK11
"Cytokine Signaling in Immune system"	0.364356435643564	0.934170410783055	0.096240602328129	0.759762402513168	1.09952229641976	2	CNN2 PRTN3
"Signaling by Interleukins"	0.364356435643564	0.934170410783055	0.096240602328129	0.759762402513168	1.09952229641976	2	CNN2 PRTN3
"Extracellular matrix organization"	0.366541353383459	0.934170410783055	0.0928481214159878	0.694359453852777	1.11157142679038	3	ELANE BSG
"The citric acid (TCA) cycle and respiratory electron transport"	0.367816091954023	0.934170410783055	0.104732821580651	-0.621212121212121	-1.12928834893192	4	NDUFS7 UQCR11 ATP5F1D BSG
"Integrin cell surface interactions"	0.372	0.934170410783055	0.0956031492204301	-0.741504511033101	-1.12457606882986	2	MADCAM1
"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins."	0.377118644067797	0.934170410783055	0.0982123351217438	-0.671641791044776	-1.13335542119665	3	NDUFS7 UQCR11 ATP5F1D
"Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"	0.380081300813008	0.934170410783055	0.0952879846194844	-0.840579710144928	-1.08844213423023	1	MADCAM1
"CDC42 GTPase cycle"	0.384313725490196	0.934170410783055	0.0925528864684773	0.826086956521739	1.09939370973853	1	ARHGAP45
"RAC1 GTPase cycle"	0.384313725490196	0.934170410783055	0.0925528864684773	0.826086956521739	1.09939370973853	1	ARHGAP45
"RHO GTPase cycle"	0.384313725490196	0.934170410783055	0.0925528864684773	0.826086956521739	1.09939370973853	1	ARHGAP45
"RHOA GTPase cycle"	0.384313725490196	0.934170410783055	0.0925528864684773	0.826086956521739	1.09939370973853	1	ARHGAP45
"Signaling by Rho GTPases"	0.384313725490196	0.934170410783055	0.0925528864684773	0.826086956521739	1.09939370973853	1	ARHGAP45
"Signaling by Rho GTPases, Miro GTPases and RHOBTB3"	0.384313725490196	0.934170410783055	0.0925528864684773	0.826086956521739	1.09939370973853	1	ARHGAP45
"Alternative complement activation"	0.392079207920792	0.934170410783055	0.0919686140000427	0.75	1.0853942227031	2	CFD GZMM
"Initial triggering of complement"	0.392079207920792	0.934170410783055	0.0919686140000427	0.75	1.0853942227031	2	CFD GZMM
"Generic Transcription Pathway"	0.40064620355412	0.934170410783055	0.0795564677235957	0.537988874524011	1.07276055055105	7	ARID3A TCF3
"RNA Polymerase II Transcription"	0.40064620355412	0.934170410783055	0.0795564677235957	0.537988874524011	1.07276055055105	7	ARID3A TCF3
"Transport of small molecules"	0.402255639097744	0.934170410783055	0.0875697115548511	0.673888101808883	1.0787996831733	3	ATP8B3 ABCA7
Myogenesis	0.407843137254902	0.934170410783055	0.0891647117820678	0.811594202898551	1.08010610079575	1	TCF3
"RUNX1 regulates transcription of genes involved in differentiation of HSCs"	0.407843137254902	0.934170410783055	0.0891647117820678	0.811594202898551	1.08010610079575	1	TCF3
"Transcriptional regulation by RUNX1"	0.407843137254902	0.934170410783055	0.0891647117820678	0.811594202898551	1.08010610079575	1	TCF3
"Signaling by Receptor Tyrosine Kinases"	0.411494252873563	0.934170410783055	0.0978773277424561	-0.583021168030111	-1.05986182457677	4	FGF22 SHC2
"Adaptive Immune System"	0.415254237288136	0.934170410783055	0.0925528864684773	-0.643789537490574	-1.08635640627666	3	MADCAM1
"Antagonism of Activin by Follistatin"	0.427450980392157	0.934170410783055	0.0865399737444125	0.797101449275362	1.06081849185297	1	FSTL3
"Post-translational protein phosphorylation"	0.427450980392157	0.934170410783055	0.0865399737444125	0.797101449275362	1.06081849185297	1	FSTL3
"Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)"	0.427450980392157	0.934170410783055	0.0865399737444125	0.797101449275362	1.06081849185297	1	FSTL3
"Signaling by Activin"	0.427450980392157	0.934170410783055	0.0865399737444125	0.797101449275362	1.06081849185297	1	FSTL3
"Signaling by TGFB family members"	0.427450980392157	0.934170410783055	0.0865399737444125	0.797101449275362	1.06081849185297	1	FSTL3
"Metabolism of RNA"	0.454545454545455	0.934170410783055	0.0751181635276302	0.567022775871498	1.0410935734488	5	PTBP1 RPS15 ADAT3 WDR18
"G alpha (q) signalling events"	0.456862745098039	0.934170410783055	0.0828962134571565	0.782608695652174	1.04153088291019	1	KISS1R
"GPCR downstream signalling"	0.456862745098039	0.934170410783055	0.0828962134571565	0.782608695652174	1.04153088291019	1	KISS1R
"Peptide ligand-binding receptors"	0.456862745098039	0.934170410783055	0.0828962134571565	0.782608695652174	1.04153088291019	1	KISS1R
"RAS processing"	0.457317073170732	0.934170410783055	0.0847985102819124	-0.811594202898551	-1.05090964684298	1	ABHD17A
"Metabolism of lipids"	0.485057471264368	0.934170410783055	0.0883594442500905	-0.536532668041609	-0.975351365743645	4	GPX4 MED16 CSNK1G2
"Neuronal System"	0.497029702970297	0.934170410783055	0.0789209638180035	0.696021205947737	1.00727652775269	2	GRIN3B
"Defective B3GALTL causes Peters-plus syndrome (PpS)"	0.519607843137255	0.934170410783055	0.0760837160951725	0.753623188405797	1.00295566502462	1	ADAMTSL5
"Diseases associated with O-glycosylation of proteins"	0.519607843137255	0.934170410783055	0.0760837160951725	0.753623188405797	1.00295566502462	1	ADAMTSL5
"Diseases of glycosylation"	0.519607843137255	0.934170410783055	0.0760837160951725	0.753623188405797	1.00295566502462	1	ADAMTSL5
"Diseases of metabolism"	0.519607843137255	0.934170410783055	0.0760837160951725	0.753623188405797	1.00295566502462	1	ADAMTSL5
"O-glycosylation of TSR domain-containing proteins"	0.519607843137255	0.934170410783055	0.0760837160951725	0.753623188405797	1.00295566502462	1	ADAMTSL5
"O-linked glycosylation"	0.519607843137255	0.934170410783055	0.0760837160951725	0.753623188405797	1.00295566502462	1	ADAMTSL5
Disease	0.52020202020202	0.934170410783055	0.0897104652742981	-0.459924956265531	-0.955929690273269	6	FGF22
"Carboxyterminal post-translational modifications of tubulin"	0.520325203252033	0.934170410783055	0.0778840111977068	-0.782608695652174	-1.01337715945573	1	TPGS1
"Developmental Biology"	0.523569023569024	0.934170410783055	0.0679922591544058	0.53258895762427	0.977870668810806	5	TCF3 EFNA2 RPS15
"Complex I biogenesis"	0.536585365853659	0.934170410783055	0.0762797180809272	-0.768115942028986	-0.99461091576211	1	NDUFS7
Hemostasis	0.545112781954887	0.934170410783055	0.0714786287425507	0.611649991529722	0.979165258006515	3	CFD PRTN3
"EPH-Ephrin signaling"	0.566666666666667	0.934170410783055	0.0716527366829457	0.72463768115942	0.964380447139062	1	EFNA2
"EPH-ephrin mediated repulsion of cells"	0.566666666666667	0.934170410783055	0.0716527366829457	0.72463768115942	0.964380447139062	1	EFNA2
"EPHA-mediated growth cone collapse"	0.566666666666667	0.934170410783055	0.0716527366829457	0.72463768115942	0.964380447139062	1	EFNA2
"Axon guidance"	0.627722772277228	0.934170410783055	0.0670512579829467	0.647058823529412	0.936418545077185	2	EFNA2 RPS15
"Nervous system development"	0.627722772277228	0.934170410783055	0.0670512579829467	0.647058823529412	0.936418545077185	2	EFNA2 RPS15
"Regulation of TP53 Activity"	0.63	0.934170410783055	0.0673623868166279	-0.617647058823529	-0.936732131768627	2	STK11 MBD3
"Post-translational protein modification"	0.6331569664903	0.934170410783055	0.0610363728309177	0.524146333495087	0.903091299837772	4	FSTL3 ADAMTSL5
"ABC transporters in lipid homeostasis"	0.63921568627451	0.934170410783055	0.0656813601934011	0.666666666666667	0.887230011367937	1	ABCA7
"ABC-family proteins mediated transport"	0.63921568627451	0.934170410783055	0.0656813601934011	0.666666666666667	0.887230011367937	1	ABCA7
"AMPK inhibits chREBP transcriptional activation activity"	0.648373983739837	0.934170410783055	0.0667426134241917	-0.710144927536232	-0.919545940987611	1	STK11
"Energy dependent regulation of mTOR by LKB1-AMPK"	0.648373983739837	0.934170410783055	0.0667426134241917	-0.710144927536232	-0.919545940987611	1	STK11
"FOXO-mediated transcription"	0.648373983739837	0.934170410783055	0.0667426134241917	-0.710144927536232	-0.919545940987611	1	STK11
"FOXO-mediated transcription of cell death genes"	0.648373983739837	0.934170410783055	0.0667426134241917	-0.710144927536232	-0.919545940987611	1	STK11
"Integration of energy metabolism"	0.648373983739837	0.934170410783055	0.0667426134241917	-0.710144927536232	-0.919545940987611	1	STK11
"MTOR signalling"	0.648373983739837	0.934170410783055	0.0667426134241917	-0.710144927536232	-0.919545940987611	1	STK11
"Regulation of TP53 Activity through Phosphorylation"	0.648373983739837	0.934170410783055	0.0667426134241917	-0.710144927536232	-0.919545940987611	1	STK11
"Epigenetic regulation of gene expression"	0.676	0.934170410783055	0.0639271933359996	-0.588235294117647	-0.892125839779644	2	MBD3 POLR2E
"Positive epigenetic regulation of rRNA expression"	0.676	0.934170410783055	0.0639271933359996	-0.588235294117647	-0.892125839779644	2	MBD3 POLR2E
"RNA Polymerase I Promoter Clearance"	0.676	0.934170410783055	0.0639271933359996	-0.588235294117647	-0.892125839779644	2	MBD3 POLR2E
"RNA Polymerase I Transcription"	0.676	0.934170410783055	0.0639271933359996	-0.588235294117647	-0.892125839779644	2	MBD3 POLR2E
"RNA Polymerase I Transcription Initiation"	0.676	0.934170410783055	0.0639271933359996	-0.588235294117647	-0.892125839779644	2	MBD3 POLR2E
"Mitochondrial biogenesis"	0.682	0.934170410783055	0.0635007968065945	-0.581357593460997	-0.881695023173731	2	ATP5F1D
"Organelle biogenesis and maintenance"	0.682	0.934170410783055	0.0635007968065945	-0.581357593460997	-0.881695023173731	2	ATP5F1D
"Creatine metabolism"	0.701219512195122	0.934170410783055	0.0629394692018967	-0.681159420289855	-0.882013453600362	1	GAMT
"Transcriptional Regulation by MECP2"	0.701219512195122	0.934170410783055	0.0629394692018967	-0.681159420289855	-0.882013453600362	1	GAMT
"Metabolism of proteins"	0.705387205387205	0.934170410783055	0.05378728077603	0.440440333391789	0.808679333695327	5	FSTL3 ADAMTSL5 RPS15
"Common Pathway of Fibrin Clot Formation"	0.713725490196079	0.934170410783055	0.0603786357920401	0.652173913043478	0.867942402425156	1	PRTN3
"Formation of Fibrin Clot (Clotting Cascade)"	0.713725490196079	0.934170410783055	0.0603786357920401	0.652173913043478	0.867942402425156	1	PRTN3
"Other interleukin signaling"	0.713725490196079	0.934170410783055	0.0603786357920401	0.652173913043478	0.867942402425156	1	PRTN3
"Major pathway of rRNA processing in the nucleolus and cytosol"	0.730693069306931	0.934170410783055	0.0597317976364411	0.588235294117647	0.851289586433805	2	RPS15 WDR18
"rRNA processing"	0.730693069306931	0.934170410783055	0.0597317976364411	0.588235294117647	0.851289586433805	2	RPS15 WDR18
"rRNA processing in the nucleus and cytosol"	0.730693069306931	0.934170410783055	0.0597317976364411	0.588235294117647	0.851289586433805	2	RPS15 WDR18
"Signaling by FGFR"	0.730932203389831	0.934170410783055	0.0629394692018967	-0.458592997017216	-0.77384830161295	3	FGF22
"Signaling by FGFR2"	0.730932203389831	0.934170410783055	0.0629394692018967	-0.458592997017216	-0.77384830161295	3	FGF22
"Arachidonic acid metabolism"	0.737804878048781	0.934170410783055	0.0605092988656667	-0.666666666666667	-0.863247209906737	1	GPX4
"Biosynthesis of D-series resolvins"	0.737804878048781	0.934170410783055	0.0605092988656667	-0.666666666666667	-0.863247209906737	1	GPX4
"Biosynthesis of DHA-derived SPMs"	0.737804878048781	0.934170410783055	0.0605092988656667	-0.666666666666667	-0.863247209906737	1	GPX4
"Biosynthesis of E-series 18(R)-resolvins"	0.737804878048781	0.934170410783055	0.0605092988656667	-0.666666666666667	-0.863247209906737	1	GPX4
"Biosynthesis of E-series 18(S)-resolvins"	0.737804878048781	0.934170410783055	0.0605092988656667	-0.666666666666667	-0.863247209906737	1	GPX4
"Biosynthesis of EPA-derived SPMs"	0.737804878048781	0.934170410783055	0.0605092988656667	-0.666666666666667	-0.863247209906737	1	GPX4
"Biosynthesis of aspirin-triggered D-series resolvins"	0.737804878048781	0.934170410783055	0.0605092988656667	-0.666666666666667	-0.863247209906737	1	GPX4
"Biosynthesis of specialized proresolving mediators (SPMs)"	0.737804878048781	0.934170410783055	0.0605092988656667	-0.666666666666667	-0.863247209906737	1	GPX4
"Fatty acid metabolism"	0.737804878048781	0.934170410783055	0.0605092988656667	-0.666666666666667	-0.863247209906737	1	GPX4
"Synthesis of 12-eicosatetraenoic acid derivatives"	0.737804878048781	0.934170410783055	0.0605092988656667	-0.666666666666667	-0.863247209906737	1	GPX4
"Synthesis of 15-eicosatetraenoic acid derivatives"	0.737804878048781	0.934170410783055	0.0605092988656667	-0.666666666666667	-0.863247209906737	1	GPX4
"Synthesis of 5-eicosatetraenoic acids"	0.737804878048781	0.934170410783055	0.0605092988656667	-0.666666666666667	-0.863247209906737	1	GPX4
"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S"	0.73921568627451	0.934170410783055	0.0587185879555941	0.63768115942029	0.848654793482374	1	RPS15
"Cap-dependent Translation Initiation"	0.73921568627451	0.934170410783055	0.0587185879555941	0.63768115942029	0.848654793482374	1	RPS15
"Cellular response to starvation"	0.73921568627451	0.934170410783055	0.0587185879555941	0.63768115942029	0.848654793482374	1	RPS15
"Cellular responses to stimuli"	0.73921568627451	0.934170410783055	0.0587185879555941	0.63768115942029	0.848654793482374	1	RPS15
"Cellular responses to stress"	0.73921568627451	0.934170410783055	0.0587185879555941	0.63768115942029	0.848654793482374	1	RPS15
"Eukaryotic Translation Elongation"	0.73921568627451	0.934170410783055	0.0587185879555941	0.63768115942029	0.848654793482374	1	RPS15
"Eukaryotic Translation Initiation"	0.73921568627451	0.934170410783055	0.0587185879555941	0.63768115942029	0.848654793482374	1	RPS15
"Eukaryotic Translation Termination"	0.73921568627451	0.934170410783055	0.0587185879555941	0.63768115942029	0.848654793482374	1	RPS15
"Formation of a pool of free 40S subunits"	0.73921568627451	0.934170410783055	0.0587185879555941	0.63768115942029	0.848654793482374	1	RPS15
"Formation of the ternary complex, and subsequently, the 43S complex"	0.73921568627451	0.934170410783055	0.0587185879555941	0.63768115942029	0.848654793482374	1	RPS15
"GTP hydrolysis and joining of the 60S ribosomal subunit"	0.73921568627451	0.934170410783055	0.0587185879555941	0.63768115942029	0.848654793482374	1	RPS15
"L13a-mediated translational silencing of Ceruloplasmin expression"	0.73921568627451	0.934170410783055	0.0587185879555941	0.63768115942029	0.848654793482374	1	RPS15
"Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)"	0.73921568627451	0.934170410783055	0.0587185879555941	0.63768115942029	0.848654793482374	1	RPS15
"Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)"	0.73921568627451	0.934170410783055	0.0587185879555941	0.63768115942029	0.848654793482374	1	RPS15
"Nonsense-Mediated Decay (NMD)"	0.73921568627451	0.934170410783055	0.0587185879555941	0.63768115942029	0.848654793482374	1	RPS15
"Peptide chain elongation"	0.73921568627451	0.934170410783055	0.0587185879555941	0.63768115942029	0.848654793482374	1	RPS15
"Regulation of expression of SLITs and ROBOs"	0.73921568627451	0.934170410783055	0.0587185879555941	0.63768115942029	0.848654793482374	1	RPS15
"Response of EIF2AK4 (GCN2) to amino acid deficiency"	0.73921568627451	0.934170410783055	0.0587185879555941	0.63768115942029	0.848654793482374	1	RPS15
"Ribosomal scanning and start codon recognition"	0.73921568627451	0.934170410783055	0.0587185879555941	0.63768115942029	0.848654793482374	1	RPS15
"SRP-dependent cotranslational protein targeting to membrane"	0.73921568627451	0.934170410783055	0.0587185879555941	0.63768115942029	0.848654793482374	1	RPS15
"Selenoamino acid metabolism"	0.73921568627451	0.934170410783055	0.0587185879555941	0.63768115942029	0.848654793482374	1	RPS15
"Selenocysteine synthesis"	0.73921568627451	0.934170410783055	0.0587185879555941	0.63768115942029	0.848654793482374	1	RPS15
"Signaling by ROBO receptors"	0.73921568627451	0.934170410783055	0.0587185879555941	0.63768115942029	0.848654793482374	1	RPS15
Translation	0.73921568627451	0.934170410783055	0.0587185879555941	0.63768115942029	0.848654793482374	1	RPS15
"Translation initiation complex formation"	0.73921568627451	0.934170410783055	0.0587185879555941	0.63768115942029	0.848654793482374	1	RPS15
"Viral mRNA Translation"	0.73921568627451	0.934170410783055	0.0587185879555941	0.63768115942029	0.848654793482374	1	RPS15
"Cristae formation"	0.768292682926829	0.934170410783055	0.0585937568945671	-0.652173913043478	-0.844480966213112	1	ATP5F1D
"Formation of ATP by chemiosmotic coupling"	0.768292682926829	0.934170410783055	0.0585937568945671	-0.652173913043478	-0.844480966213112	1	ATP5F1D
"Antigen processing: Ubiquitination & Proteasome degradation"	0.77	0.934170410783055	0.0577308549299813	-0.514705882352941	-0.780610109807189	2	CDC34 RNF126
"Class I MHC mediated antigen processing & presentation"	0.77	0.934170410783055	0.0577308549299813	-0.514705882352941	-0.780610109807189	2	CDC34 RNF126
"PPARA activates gene expression"	0.794715447154472	0.934170410783055	0.0570059526582387	-0.63768115942029	-0.825714722519487	1	MED16
"Regulation of lipid metabolism by PPARalpha"	0.794715447154472	0.934170410783055	0.0570059526582387	-0.63768115942029	-0.825714722519487	1	MED16
"Transcriptional regulation of white adipocyte differentiation"	0.794715447154472	0.934170410783055	0.0570059526582387	-0.63768115942029	-0.825714722519487	1	MED16
"Sphingolipid de novo biosynthesis"	0.796	0.934170410783055	0.0561766586307176	-0.485294117647059	-0.736003817818207	2	CSNK1G2 PLPP2
"Sphingolipid metabolism"	0.796	0.934170410783055	0.0561766586307176	-0.485294117647059	-0.736003817818207	2	CSNK1G2 PLPP2
"Signal Transduction"	0.811209439528024	0.934170410783055	0.0741758965588009	-0.281925660112331	-0.737427854289375	12	FGF22 SHC2 PLPPR3 ABHD17A
"tRNA modification in the nucleus and cytosol"	0.813725490196078	0.934170410783055	0.0542315935495841	0.594202898550725	0.790791966654031	1	ADAT3
"tRNA processing"	0.813725490196078	0.934170410783055	0.0542315935495841	0.594202898550725	0.790791966654031	1	ADAT3
"C-type lectin receptors (CLRs)"	0.821138211382114	0.934170410783055	0.0554793308704233	-0.623188405797102	-0.806948478825863	1	CDC34
"CLEC7A (Dectin-1) signaling"	0.821138211382114	0.934170410783055	0.0554793308704233	-0.623188405797102	-0.806948478825863	1	CDC34
"Downstream TCR signaling"	0.821138211382114	0.934170410783055	0.0554793308704233	-0.623188405797102	-0.806948478825863	1	CDC34
"FCERI mediated NF-kB activation"	0.821138211382114	0.934170410783055	0.0554793308704233	-0.623188405797102	-0.806948478825863	1	CDC34
"Fc epsilon receptor (FCERI) signaling"	0.821138211382114	0.934170410783055	0.0554793308704233	-0.623188405797102	-0.806948478825863	1	CDC34
"Protein ubiquitination"	0.821138211382114	0.934170410783055	0.0554793308704233	-0.623188405797102	-0.806948478825863	1	CDC34
"Synthesis of active ubiquitin: roles of E1 and E2 enzymes"	0.821138211382114	0.934170410783055	0.0554793308704233	-0.623188405797102	-0.806948478825863	1	CDC34
"TCR signaling"	0.821138211382114	0.934170410783055	0.0554793308704233	-0.623188405797102	-0.806948478825863	1	CDC34
"Chromatin modifying enzymes"	0.847560975609756	0.934170410783055	0.0540088272801684	-0.608695652173913	-0.788182235132238	1	MBD3
"Chromatin organization"	0.847560975609756	0.934170410783055	0.0540088272801684	-0.608695652173913	-0.788182235132238	1	MBD3
"ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression"	0.847560975609756	0.934170410783055	0.0540088272801684	-0.608695652173913	-0.788182235132238	1	MBD3
"HDACs deacetylate histones"	0.847560975609756	0.934170410783055	0.0540088272801684	-0.608695652173913	-0.788182235132238	1	MBD3
"PTEN Regulation"	0.847560975609756	0.934170410783055	0.0540088272801684	-0.608695652173913	-0.788182235132238	1	MBD3
"Potential therapeutics for SARS"	0.847560975609756	0.934170410783055	0.0540088272801684	-0.608695652173913	-0.788182235132238	1	MBD3
"Regulation of PTEN gene transcription"	0.847560975609756	0.934170410783055	0.0540088272801684	-0.608695652173913	-0.788182235132238	1	MBD3
"Regulation of TP53 Activity through Acetylation"	0.847560975609756	0.934170410783055	0.0540088272801684	-0.608695652173913	-0.788182235132238	1	MBD3
"SARS-CoV Infections"	0.847560975609756	0.934170410783055	0.0540088272801684	-0.608695652173913	-0.788182235132238	1	MBD3
"Basigin interactions"	0.865853658536585	0.934170410783055	0.0530212512043078	-0.594202898550725	-0.769415991438613	1	BSG
"Cell surface interactions at the vascular wall"	0.865853658536585	0.934170410783055	0.0530212512043078	-0.594202898550725	-0.769415991438613	1	BSG
"Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT)"	0.865853658536585	0.934170410783055	0.0530212512043078	-0.594202898550725	-0.769415991438613	1	BSG
"Disorders of transmembrane transporters"	0.865853658536585	0.934170410783055	0.0530212512043078	-0.594202898550725	-0.769415991438613	1	BSG
"Proton-coupled monocarboxylate transport"	0.865853658536585	0.934170410783055	0.0530212512043078	-0.594202898550725	-0.769415991438613	1	BSG
"Pyruvate metabolism"	0.865853658536585	0.934170410783055	0.0530212512043078	-0.594202898550725	-0.769415991438613	1	BSG
"Pyruvate metabolism and Citric Acid (TCA) cycle"	0.865853658536585	0.934170410783055	0.0530212512043078	-0.594202898550725	-0.769415991438613	1	BSG
"SLC transporter disorders"	0.865853658536585	0.934170410783055	0.0530212512043078	-0.594202898550725	-0.769415991438613	1	BSG
"SLC-mediated transmembrane transport"	0.865853658536585	0.934170410783055	0.0530212512043078	-0.594202898550725	-0.769415991438613	1	BSG
"Transport of bile salts and organic acids, metal ions and amine compounds"	0.865853658536585	0.934170410783055	0.0530212512043078	-0.594202898550725	-0.769415991438613	1	BSG
"Abortive elongation of HIV-1 transcript in the absence of Tat"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Activation of HOX genes during differentiation"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Activation of anterior HOX genes in hindbrain development during early embryogenesis"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"B-WICH complex positively regulates rRNA expression"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Cell Cycle"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Chromosome Maintenance"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Cytosolic sensors of pathogen-associated DNA "	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"DNA Repair"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Dual incision in TC-NER"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"ESR-mediated signaling"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Estrogen-dependent gene expression"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Formation of HIV elongation complex in the absence of HIV Tat"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Formation of HIV-1 elongation complex containing HIV-1 Tat"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Formation of RNA Pol II elongation complex "	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Formation of TC-NER Pre-Incision Complex"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Formation of the Early Elongation Complex"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Formation of the HIV-1 Early Elongation Complex"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Gap-filling DNA repair synthesis and ligation in TC-NER"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Gene Silencing by RNA"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"HIV Infection"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"HIV Life Cycle"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"HIV Transcription Elongation"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"HIV Transcription Initiation"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"HIV elongation arrest and recovery"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Inhibition of DNA recombination at telomere"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Late Phase of HIV Life Cycle"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"MicroRNA (miRNA) biogenesis"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Negative epigenetic regulation of rRNA expression"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"NoRC negatively regulates rRNA expression"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Nucleotide Excision Repair"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"PIWI-interacting RNA (piRNA) biogenesis"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Pausing and recovery of HIV elongation"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Pausing and recovery of Tat-mediated HIV elongation"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"RNA Pol II CTD phosphorylation and interaction with CE"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"RNA Pol II CTD phosphorylation and interaction with CE during HIV infection"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"RNA Polymerase I Promoter Escape"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"RNA Polymerase I Transcription Termination"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"RNA Polymerase II HIV Promoter Escape"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"RNA Polymerase II Pre-transcription Events"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"RNA Polymerase II Promoter Escape"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"RNA Polymerase II Transcription Elongation"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"RNA Polymerase II Transcription Initiation"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"RNA Polymerase II Transcription Initiation And Promoter Clearance"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"RNA Polymerase II Transcription Pre-Initiation And Promoter Opening"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"RNA Polymerase III Abortive And Retractive Initiation"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"RNA Polymerase III Chain Elongation"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"RNA Polymerase III Transcription"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"RNA Polymerase III Transcription Initiation"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"RNA Polymerase III Transcription Initiation From Type 1 Promoter"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"RNA Polymerase III Transcription Initiation From Type 2 Promoter"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"RNA Polymerase III Transcription Initiation From Type 3 Promoter"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"RNA Polymerase III Transcription Termination"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"RNA polymerase II transcribes snRNA genes"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Signaling by FGFR2 IIIa TM"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Signaling by Nuclear Receptors"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"TP53 Regulates Transcription of DNA Repair Genes"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Tat-mediated HIV elongation arrest and recovery"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Tat-mediated elongation of the HIV-1 transcript"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Telomere Maintenance"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Transcription of the HIV genome"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Transcription-Coupled Nucleotide Excision Repair (TC-NER)"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Transcriptional regulation by small RNAs"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Viral Messenger RNA Synthesis"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"mRNA Capping"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"mRNA Splicing - Minor Pathway"	0.890243902439024	0.934170410783055	0.0517405459873163	-0.579710144927536	-0.750649747744989	1	POLR2E
"Infectious disease"	0.902255639097744	0.937713513942957	0.0475434194201301	0.402985074626866	0.645122194121072	3	RPS15 POLR2E MBD3
"Olfactory Signaling Pathway"	0.902439024390244	0.937713513942957	0.0511147954416412	-0.565217391304348	-0.731883504051364	1	REEP6
"Sensory Perception"	0.902439024390244	0.937713513942957	0.0511147954416412	-0.565217391304348	-0.731883504051364	1	REEP6
"Influenza Infection"	0.926732673267327	0.947623514696685	0.048701086452153	0.446234451846716	0.645787061340681	2	RPS15 POLR2E
"Influenza Viral RNA Transcription and Replication"	0.926732673267327	0.947623514696685	0.048701086452153	0.446234451846716	0.645787061340681	2	RPS15 POLR2E
"Disassembly of the destruction complex and recruitment of AXIN to the membrane"	0.926829268292683	0.947623514696685	0.0498907356726307	-0.550724637681159	-0.713117260357739	1	CSNK1G2
"Signaling by WNT"	0.926829268292683	0.947623514696685	0.0498907356726307	-0.550724637681159	-0.713117260357739	1	CSNK1G2
"TCF dependent signaling in response to WNT"	0.926829268292683	0.947623514696685	0.0498907356726307	-0.550724637681159	-0.713117260357739	1	CSNK1G2
"Metabolism of amino acids and derivatives"	0.96	0.978402555910543	0.0475434194201301	-0.367647058823529	-0.557578649862278	2	GAMT RPS15
"Class A/1 (Rhodopsin-like receptors)"	0.972	0.981227848101266	0.0469758727821845	-0.352608022872209	-0.534770238480446	2	PLPPR3
"GPCR ligand binding"	0.972	0.981227848101266	0.0469758727821845	-0.352608022872209	-0.534770238480446	2	PLPPR3
"Signaling by GPCR"	0.972	0.981227848101266	0.0469758727821845	-0.352608022872209	-0.534770238480446	2	PLPPR3
"Mitochondrial transcription initiation"	1	1	0.044774889329693	0.507246376811594	0.675066312997343	1	POLRMT
"Transcription from mitochondrial promoters"	1	1	0.044774889329693	0.507246376811594	0.675066312997343	1	POLRMT
"Transcriptional activation of mitochondrial biogenesis"	1	1	0.044774889329693	0.507246376811594	0.675066312997343	1	POLRMT
